Guardant Health (GH) reported Q3 EPS of ($1.18), $0.21 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $117.4 million versus the consensus estimate of $118.08 million.
Guardant Health (GH) reported Q3 EPS of ($1.18), $0.21 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $117.4 million versus the consensus estimate of $118.08 million.